Cell
Volume 173, Issue 7, 14 June 2018, Pages 1770-1782.e14
ArticleInactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
metastatic castration-resistant prostate cancer
CDK12
gene fusions
focal tandem duplications
neoantigens
immunotherapy
Cited by (0)
© 2018 Elsevier Inc.